https://www.selleckchem.com/pr....oducts/l-name-hcl.ht
ith high-grade soft tissue sarcoma. Innovations in comorbidity management may be a means for the improvement of oncological outcomes in soft tissue sarcoma. Given the difficulties in conducting standard randomized control studies in this field, data accumulation from real-world cases appears to be the most practical approach in establishing and applying strategies for the treatment of patients with comorbidities or elderly patients. To investigate the effect of a single nucleotide polymorphism (SNP) in transmembrane protein 182 (TMEM
Like
Comment
Share
